Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0296 Transporter Info
Gene Name	SLC35C1
Transporter Name	GDP-fucose transporter 1
Gene ID	55343
UniProt ID	Q96A29

Post-Translational Modification of This DT
Overview of SLC35C1 Modification Sites with Functional and Structural Information
Sequence	M N R A P L K R S R I L H M A L T G A S D P S A E A E A N G E K P F L L R A L Q I A L V V S L Y W V T S I S M V F L N K Y L L D S P S L R L D T P I F V T F Y Q C L V T T L L C K G L S A L A A C C P G A V D F P S L R L D L R V A R S V L P L S V V F I G M I T F N N L C L K Y V G V A F Y N V G R S L T T V F N V L L S Y L L L K Q T T S F Y A L L T C G I I I G G F W L G V D Q E G A E G T L S W L G T V F G V L A S L C V S L N A I Y T T K V L P A V D G S I W R L T F Y N N V N A C I L F L P L L L L L G E L Q A L R D F A Q L G S A H F W G M M T L G G L F G F A I G Y V T G L Q I K F T S P L T H N V S G T A K A C A Q T V L A V L Y Y E E T K S F L W W T S N M M V L G G S S A Y T W V R G W E M K K T P E E P S P K D S E K S A M G V
PTM type	X-Phosphorylation X-S-palmitoylation X: Amino Acid

Phosphorylation
Serine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35C1			[1]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	226
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35C1 Serine 226 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC35C1			[2] , [3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	353
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35C1 Serine 353 has the potential to affect its expression or activity.
Threonine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35C1			[4]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	291
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35C1 Threonine 291 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC35C1			[4]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	301
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35C1 Threonine 301 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC35C1			[5] , [6]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	348
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35C1 Threonine 348 has the potential to affect its expression or activity.
S-palmitoylation
Cystine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35C1			[7]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	97
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-palmitoylation at SLC35C1 Cystine 97 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC35C1			[7]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	98
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-palmitoylation at SLC35C1 Cystine 98 has the potential to affect its expression or activity.

References
1	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
2	Deep Coverage of Global Protein Expression and Phosphorylation in Breast Tumor Cell Lines Using TMT 10-plex Isobaric Labeling. J Proteome Res. 2017 Mar 3;16(3):1121-1132.
3	Specificity of Phosphorylation Responses to Mitogen Activated Protein (MAP) Kinase Pathway Inhibitors in Melanoma Cells. Mol Cell Proteomics. 2018 Apr;17(4):550-564.
4	Motif-specific sampling of phosphoproteomes. J Proteome Res. 2008 May;7(5):2140-50.
5	Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res. 2013 Jun 7;12(6):2414-21.
6	Phosphoproteome dynamics in onset and maintenance of oncogene-induced senescence. Mol Cell Proteomics. 2014 Aug;13(8):2089-100.
7	Selective Enrichment and Direct Analysis of Protein S-Palmitoylation Sites. J Proteome Res. 2018 May 4;17(5):1907-1922.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence